Whether You Can Actually Raise a Low AMH

What AMH Actually Tracks

Anti-Müllerian hormone is produced by small ovarian follicles, and the level in a blood draw is used to estimate roughly how many eggs are available that cycle, not how many eggs remain over an entire lifetime. It is considered gonadotropin-independent and relatively stable across the menstrual cycle, which is part of why a single blood draw is treated as a reasonably reliable snapshot rather than something that needs to be timed to a specific cycle day 1Ref 1Practice Committee of ASRM (2020).Testing and interpreting measures of ovarian reserve: a committee opinion.AMH is gonadotropin-independent and relatively cycle-stable, declines with age, and is useful for estimating response to stimulation; a low ovarian-reserve result does not by itself mean a woman cannot conceive..

AMH — a hormone made by small resting follicles, used as one marker of ovarian reserve

That stability is also why AMH tends to decline gradually and predictably with age rather than swinging month to month. A result compared against what AMH measures and against age-specific reference ranges tells you where you sit relative to a typical trajectory for someone your age — it does not tell you whether you will conceive this year, next year, or ever.

Do Supplements or Diet Actually Raise It?

No clinical trial establishes that any supplement, diet, or over-the-counter regimen raises a measured AMH level. Claims that DHEA, CoQ10, myo-inositol, or a particular "fertility cleanse" will restore a low number are common in fertility marketing, but they aren't supported by the kind of evidence cited in this article.

Assisted reproduction has its own version of this gap between marketing and data. Regulators who formally grade the evidence for marketed IVF add-ons rate most of them, individually, as lacking good evidence of benefit, and some carry a real risk of harm 5Ref 5Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.Most marketed IVF add-ons are rated by regulators as lacking good evidence of benefit, illustrating the general gap between fertility marketing and supporting evidence.. The same skepticism is worth applying to anything sold specifically as an AMH booster: a low number changing after a supplement is started is far more likely to reflect normal test-to-test variation than a real physiological shift.

a disappointing AMH result is common, and chasing a higher number is rarely where the useful next step lives

Why a Low Number Shouldn't Automatically Add Extra Procedures

A low AMH result is sometimes used to justify add-on procedures that aren't specifically indicated by a reserve number on its own. Intracytoplasmic sperm injection — injecting a single sperm directly into an egg — is one example: current professional guidance holds that, absent male-factor infertility or a prior history of fertilization failure, routine ICSI on all eggs has not been shown to improve live-birth rates 3Ref 3Practice Committees of ASRM and SART (2026).Intracytoplasmic sperm injection for nonmale factor indications: a committee opinion.Absent male factor or prior fertilization failure, routine ICSI on all oocytes does not improve live-birth rates, supporting caution against add-on procedures not specifically indicated by a low AMH result alone.. A low AMH by itself is not that indication, and it's worth asking specifically what a proposed add-on is meant to fix before agreeing to it.

Outside of add-on procedures, there isn't a comparable lifestyle lever with strong evidence behind it either. Diet quality, exercise, and stress management support general health during a fertility workup and any treatment that follows, but none of them has been shown to change a follicle count that's largely fixed by age and genetics.

What a Low Result Actually Changes

A low AMH result mainly changes timeline and testing strategy, not the underlying question of whether pregnancy is possible. Ovarian reserve testing is used to estimate how the ovaries are likely to respond to stimulation medication, not to predict natural conception, and a low result does not by itself mean someone cannot conceive 1Ref 1Practice Committee of ASRM (2020).Testing and interpreting measures of ovarian reserve: a committee opinion.AMH is gonadotropin-independent and relatively cycle-stable, declines with age, and is useful for estimating response to stimulation; a low ovarian-reserve result does not by itself mean a woman cannot conceive..

Within a standard fertility evaluation, ovarian reserve testing sits alongside a history and exam, an assessment of whether ovulation is occurring, a check of tubal patency, and evaluation of the male partner at the same time — not as an afterthought 2Ref 2Practice Committee of ASRM (2021).Fertility evaluation of infertile women: a committee opinion.A standard fertility evaluation includes history and exam, ovulation assessment, ovarian reserve testing, tubal patency testing, and concurrent evaluation of the male partner.. A low number typically moves a person more quickly into that fuller workup rather than closing off any particular path, including low AMH natural conception or fertility treatment.

a low ovarian reserve result does not, by itself, mean you cannot conceive 1Ref 1Practice Committee of ASRM (2020).Testing and interpreting measures of ovarian reserve: a committee opinion.AMH is gonadotropin-independent and relatively cycle-stable, declines with age, and is useful for estimating response to stimulation; a low ovarian-reserve result does not by itself mean a woman cannot conceive.

AMH and IVF: A Different Question Than "Can I Get Pregnant"

Where AMH earns its clinical weight is in planning an IVF stimulation protocol — amh and ivf are linked mainly through egg yield, since AMH helps predict roughly how many eggs a retrieval is likely to produce and what starting medication dose makes sense. It is a weaker predictor of whether a given IVF cycle ends in a live birth, since egg quality, age, and uterine factors all contribute independently of the reserve number.

At the opposite end of the range, a high AMH raises a different set of questions rather than a better one: it's often seen with polycystic ovary syndrome and mainly signals a stronger-than-typical response to stimulation, which changes how a cycle is dosed rather than guaranteeing an easier path to pregnancy.

Folic Acid and Other Preconception Advice Aren't AMH Fixes

It's worth separating general preconception health advice from anything claiming to change ovarian reserve specifically. The recommendation that anyone planning or capable of pregnancy take a daily folic acid supplement starting at least a month before conception exists to reduce the risk of neural tube defects — it is not evidence that folic acid improves fertility or raises an AMH level 4Ref 4US Preventive Services Task Force (2023).Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication.Folic acid supplementation is recommended to reduce neural tube defect risk, not because it has been shown to improve fertility or raise ovarian reserve.. Preconception health matters, but it answers a different question than the one a low AMH result raises.

This distinction matters because it's easy for a legitimate, well-supported recommendation to get repackaged as a fertility booster once it's sitting next to less-supported claims in the same article or product listing.

When a Low Number Changes the Timeline

Fecundity declines gradually starting around age 32 and more rapidly after 37, and clinical guidance recommends an expedited fertility evaluation for women over 35 after six months of trying, and a faster evaluation still after 40 1Ref 1Practice Committee of ASRM (2020).Testing and interpreting measures of ovarian reserve: a committee opinion.AMH is gonadotropin-independent and relatively cycle-stable, declines with age, and is useful for estimating response to stimulation; a low ovarian-reserve result does not by itself mean a woman cannot conceive.6Ref 6American College of Obstetricians and Gynecologists (2025).Anticipatory Counseling Regarding Ovarian-Factor Fertility Decline (Committee Statement No. 22).Fecundity decreases gradually from about age 32 and more rapidly after 37; expedited evaluation is recommended for women over 35 after six months of trying, and more immediate evaluation over 40.. A low AMH result layered on top of an age where time already matters is the combination that most often changes a timeline — not because the number itself is a countdown clock, but because it adds information to a picture where age is already the dominant variable.

If a result came from an at-home AMH test rather than a clinic-ordered lab draw, it's reasonable to bring it to a clinician for context rather than acting on it alone, since a single consumer-test number is rarely interpreted the same way a lab result embedded in a full history is.